AU2004224068A1 - Process for preparing a polymorph of rosiglitazone maleate - Google Patents

Process for preparing a polymorph of rosiglitazone maleate Download PDF

Info

Publication number
AU2004224068A1
AU2004224068A1 AU2004224068A AU2004224068A AU2004224068A1 AU 2004224068 A1 AU2004224068 A1 AU 2004224068A1 AU 2004224068 A AU2004224068 A AU 2004224068A AU 2004224068 A AU2004224068 A AU 2004224068A AU 2004224068 A1 AU2004224068 A1 AU 2004224068A1
Authority
AU
Australia
Prior art keywords
compound
rosiglitazone maleate
solvent
mixture
rosiglitazone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2004224068A
Other languages
English (en)
Inventor
Andrew Simon Craig
Robert Gordon Giles
Tim Chien Ting Ho
Michael John Sasse
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU2004224068A1 publication Critical patent/AU2004224068A1/en
Priority to AU2008237610A priority Critical patent/AU2008237610A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU2004224068A 2003-03-28 2004-03-25 Process for preparing a polymorph of rosiglitazone maleate Abandoned AU2004224068A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2008237610A AU2008237610A1 (en) 2003-03-28 2008-10-30 Process for preparing a polymorph of rosiglitazone maleate

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0307259.2A GB0307259D0 (en) 2003-03-28 2003-03-28 Process
GB0307259.2 2003-03-28
PCT/GB2004/001306 WO2004085435A1 (en) 2003-03-28 2004-03-25 Process for preparing a polymorph of rosiglitazone maleate

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2008237610A Division AU2008237610A1 (en) 2003-03-28 2008-10-30 Process for preparing a polymorph of rosiglitazone maleate

Publications (1)

Publication Number Publication Date
AU2004224068A1 true AU2004224068A1 (en) 2004-10-07

Family

ID=9955778

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2004224068A Abandoned AU2004224068A1 (en) 2003-03-28 2004-03-25 Process for preparing a polymorph of rosiglitazone maleate
AU2008237610A Abandoned AU2008237610A1 (en) 2003-03-28 2008-10-30 Process for preparing a polymorph of rosiglitazone maleate

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2008237610A Abandoned AU2008237610A1 (en) 2003-03-28 2008-10-30 Process for preparing a polymorph of rosiglitazone maleate

Country Status (18)

Country Link
US (1) US20070167494A1 (https=)
EP (1) EP1615918A1 (https=)
JP (1) JP2006521340A (https=)
KR (1) KR20050120670A (https=)
CN (1) CN1768057A (https=)
AU (2) AU2004224068A1 (https=)
BR (1) BRPI0408752A (https=)
CA (1) CA2520249A1 (https=)
EA (1) EA009331B1 (https=)
EC (1) ECSP056038A (https=)
GB (1) GB0307259D0 (https=)
IS (1) IS8087A (https=)
MA (1) MA27727A1 (https=)
MX (1) MXPA05010413A (https=)
NO (1) NO20054911L (https=)
OA (1) OA13042A (https=)
WO (1) WO2004085435A1 (https=)
ZA (1) ZA200507100B (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020137940A1 (en) 1997-12-16 2002-09-26 Smithkline Beecham P.L.C. 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical
US20040248945A1 (en) 1999-04-23 2004-12-09 Smithkline Beecham P.L.C. Thiazolidinedione derivative and its use as antidiabetic
GB2405403A (en) * 2003-08-29 2005-03-02 Cipla Ltd Rosiglitazone maleate of particular polymorphic forms and methods of preparing rosiglitazone free base
ITMI20041537A1 (it) * 2004-07-28 2004-10-28 Chemi Spa Nuova forma polimorfa del rosiglitazone maleato
CZ298424B6 (cs) * 2005-05-24 2007-09-26 Zentiva, A. S. Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel
WO2018140092A1 (en) 2017-01-27 2018-08-02 Obrien Christopher F Methods for the administration of certain vmat2 inhibitors
ES3024958T3 (en) 2017-09-21 2025-06-05 Neurocrine Biosciences Inc High dosage valbenazine formulation and compositions, methods, and kits related thereto
JP2021502959A (ja) 2017-10-10 2021-02-04 ニューロクライン バイオサイエンシーズ,インコーポレイテッド 特定のvmat2インヒビターを投与するための方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
GB9723295D0 (en) * 1997-11-04 1998-01-07 Smithkline Beecham Plc Novel process
UA67844C2 (uk) * 1999-04-23 2004-07-15 Смітклайн Бічам Плс Поліморф 5-[4-[2-(n-метил-n-(2-піридил)аміно)етокси]бензил]тіазолідин-2,4-діону солі малеїнової кислоти
PL351685A1 (en) * 1999-04-23 2003-06-02 Smithkline Beecham Plc Novel pharmaceutical
DE60004658T2 (de) * 1999-04-23 2004-06-24 Smithkline Beecham Plc, Brentford Thiazolidindionderivat und seine verwendung als antidiabetikum
CZ2003864A3 (cs) * 2000-09-26 2004-01-14 Dr. Reddy´S Research Foundation Nové polymorfní formy 5-[4-[2-[N-methyl-N-(2-pyridyl)amino]ethoxy]benzyl]thiazolidin-2,4-dion-maleátu a způsob jejich přípravy

Also Published As

Publication number Publication date
OA13042A (en) 2006-11-10
IS8087A (is) 2005-10-24
EA200501527A1 (ru) 2006-02-24
EA009331B1 (ru) 2007-12-28
CN1768057A (zh) 2006-05-03
MXPA05010413A (es) 2005-11-04
BRPI0408752A (pt) 2006-03-28
ZA200507100B (en) 2006-07-26
NO20054911L (no) 2005-10-24
KR20050120670A (ko) 2005-12-22
AU2008237610A1 (en) 2008-11-27
US20070167494A1 (en) 2007-07-19
JP2006521340A (ja) 2006-09-21
WO2004085435A1 (en) 2004-10-07
EP1615918A1 (en) 2006-01-18
CA2520249A1 (en) 2004-10-07
MA27727A1 (fr) 2006-01-02
ECSP056038A (es) 2006-01-27
GB0307259D0 (en) 2003-05-07

Similar Documents

Publication Publication Date Title
AU2008237610A1 (en) Process for preparing a polymorph of rosiglitazone maleate
US8722722B2 (en) Raltegravir salts and crystalline forms thereof
WO2003051818A1 (en) A novel polymorph of sertraline hydrochloride and composition containing thereof, novel methods for preparation of sertraline hydrochloride polymorphs and amorphous form
WO2007109799A2 (en) Polymorphs of eszopiclone malate
EP0844997A1 (en) Novel polymorphic forms of troglitazone having enhanced anti-diabetic activity and a process for their preparation
US8063214B2 (en) Polymorphic forms of tadalafil
CA2453751A1 (en) Purification and crystalline forms of zapelon
EP1789412B1 (en) Crystalline alfuzosin base
WO2009122425A1 (en) Novel crystalline form of carvedilol dihydrogen phosphate and related processes
US20090012296A1 (en) Processes for the preparation of crystalline form beta of imatinib mesylate
CA2464961A1 (en) Polymorphous forms of rosiglitazone maleate
JP4411269B2 (ja) (r)−3−[[(4−フルオロフェニル)スルホニル]アミノ]−1,2,3,4−テトラヒドロ−9h−カルバゾール−9−プロパン酸(ラマトロバン)の熱力学的に安定な形態の結晶の製造方法
JP2020083892A (ja) ベラプロスト−314d・一水和物結晶及びその製造方法
CA2711059A1 (en) Crystalline form of abacavir that is essentially free of solvent
US7538126B2 (en) Crystalline forms of valdecoxib
AU700976B2 (en) Novel polymorphic forms of troglitazone having enhanced anti-diabetic activity and a process for their preparation
WO2006010653A1 (en) New polymorphous form of rosiglitazone maleate
EP2102202A2 (fr) Conglomerats de sels de potassium du tenatoprazole
WO2018189695A1 (en) Neratinib crystalline forms and process for preparation thereof
EP2109613A2 (en) Polymorphs of eszopiclone malate
ZA200404332B (en) A novel polymorph of sertraline hydrochloride and composition containing thereof, novel methods for preparation of sertraline hydrochloride polymorphs and amorphous form.
AU2002329687A1 (en) Purification and crystalline forms of zaleplon

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted